Skip to main content

Table 1 Changes in metabolic and renal parameters in WT and TRPV1−/− mice after 4 weeks of DOCA-salt treatment.

From: Protective Effect of TRPV1 against Renal Fibrosis via Inhibition of TGF-β/Smad Signaling in DOCA-Salt Hypertension

Parameters

WT

TRPV1 −/−

DOCA-WTa

DOCA-TRPV1−/−b

BWc (g)

28.8 ± 0.4d

28.2 ± 0.3

29.1 ± 0.5

29.7 ± 0.3

Kidney weight (mg/10 g of BW)

77.1 ± 1.5

76.5 ± 1.2

109.6 ± 3.6e

113.6 ± 3.1e

Urinary albumin (mg/24 h)

6.9 ± 0.8

6.2 ± 0.7

28.3 ± 4.8e

83.7 ± 7.1e,f

GSIg

0.13 ± 0.03

0.09 ± 0.02

0.34 ± 0.04e

0.74 ± 0.08e,f

TISh

0.29 ± 0.10

0.21 ± 0.11

2.00 ± 0.31e

3.14 ± 0.26e,f

  1. aDOCA-WT, WT mice treated with DOCA-salt.
  2. bDOCA-TRPV1−/−, TRPV1−/− mice treated with DOCA-salt.
  3. cBW, body weight.
  4. dValues are mean ± SE (n = 6 to 8).
  5. eP < 0.05 compared to control WT or TRPV1−/− mice.
  6. fP < 0.05 compared to DOCA-WT mice.
  7. gGSI, glomerulosclerosis index.
  8. hTIS, tubulointerstitial injury score.